L-type calcium channel alpha-subunit and protein kinase inhibitors modulate Rem-mediated regulation of current

Shawn M Crump1, Robert N Correll, Elizabeth A Schroder

  • 1Dept. of Physiology, MS-508, Univ. of Kentucky College of Medicine, 800 Rose St. Lexington, KY 40536-0298, USA.

Insights

Small GTPase Rem inhibits cardiac L-type Ca channels, with Ca(V)beta2a enhancing this effect. Protein kinase A (PKA) inhibition partially relieves Rem-mediated block, suggesting phosphorylation at serine 1928 is key.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Ion Channel Function

Background:

  • Cardiac voltage-gated L-type Ca channels (Ca(V)) are crucial for heart function, modulated by accessory subunits like Ca(V)beta2.
  • Small GTPases, including Rem, have been implicated in decreasing Ca channel current, but the underlying mechanisms are unclear.

Purpose of the Study:

  • To investigate the role of the L-type Ca channel alpha-subunit (Ca(V)1.2) in Ca(V)beta2-Rem inhibition of Ca channel current.
  • To determine if protein kinase A (PKA) modulation affects Ca(V)beta2-Rem inhibition of Ca channel current.

Main Methods:

  • Whole-cell patch-clamp electrophysiology in HEK-293 cells expressing Ca(V)1.2 and Ca(V)beta2a.
  • Utilized PKA inhibitors (H-89, Rp-cAMP-S) and a PKA-insensitive Ca(V)1.2 mutant (S1928A).
  • Tested Rem effects in HIT-T15 cells and embryonic ventricular myocytes.

Main Results:

  • Rem coexpression with Ca(V)1.2 reduced Ba current; Ca(V)beta2a enhanced Rem-mediated inhibition.
  • PKA inhibition partially relieved Rem-mediated current inhibition, with or without Ca(V)beta2a.
  • The PKA-insensitive Ca(V)1.2-S1928A mutant was not inhibited by Rem, indicating S1928 phosphorylation is critical.
  • Native cardiac currents in HIT-T15 cells and ventricular myocytes were also sensitive to Rem block, relieved by H-89.

Conclusions:

  • Rem regulates cardiac L-type Ca channel current.
  • Cellular kinase pathways modulate Rem-mediated channel block.
  • The Ca(V)1.2 COOH terminus is involved in Rem-dependent channel inhibition.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...